Research ArticleArticle
Enthesitis-related Arthritis: Prevalence and Complications of Associated Uveitis in Children and Adolescents From a Population-based Nationwide Study in Germany
Karoline Walscheid, Karen Glandorf, Kai Rothaus, Martina Niewerth, Jens Klotsche, Kirsten Minden and Arnd Heiligenhaus
The Journal of Rheumatology March 2020, jrheum.191085; DOI: https://doi.org/10.3899/jrheum.191085
Karoline Walscheid
K. Walscheid, MD, FEBO, Department of Ophthalmology at St. Franziskus Hospital, Muenster, and Department of Ophthalmology, University Hospital Essen, Essen; K. Glandorf, MD, K. Rothaus, MSc, Department of Ophthalmology at St. Franziskus Hospital, Muenster; M. Niewerth, MA, German Rheumatism Research Center, a Leibniz Institute, Berlin; J. Klotsche, PhD, German Rheumatism Research Center, a Leibniz Institute, and Charité – University Medicine Berlin, Institute for Social Medicine, Epidemiology and Health Economics, Berlin; K. Minden, MD, German Rheumatism Research Center, a Leibniz Institute, and Charité - University Medicine Berlin, Department of Rheumatology and Clinical Immunology, Berlin; A. Heiligenhaus, MD, Department of Ophthalmology at St. Franziskus Hospital, Muenster, and University of Duisburg-Essen, Essen, Germany. Dr. K. Walscheid and Dr. K. Glandorf contributed equally to this study. KW has received a DFG grant (WA 4449/2-1) and honoraria from Novartis. KM is funded by the Rheumastiftung and has received research grants from BMBF (FKZ, 01ER1504A), Pfizer, AbbVie, and Roche, and honoraria from AbbVie, Biermann, GSK, Medac, Sanofi. AH has received research grants from BMBF (FKZ, 01ER1504C), DFG (He 1877/19-1), Pfizer, and Novartis, and honoraria from AbbVie, Biermann, Alimera Sciences, Allergan, MSD Sharp and Dohme, Pfizer, Santen, and Xoma. Address correspondence to Dr. K. Walscheid, Department of Ophthalmology at St. Franziskus Hospital, Hohenzollernring 74, 48145 Muenster, Germany. Email: karoline.walscheid@uveitis-zentrum.de. Accepted for publication March 6, 2020.
Karen Glandorf
K. Walscheid, MD, FEBO, Department of Ophthalmology at St. Franziskus Hospital, Muenster, and Department of Ophthalmology, University Hospital Essen, Essen; K. Glandorf, MD, K. Rothaus, MSc, Department of Ophthalmology at St. Franziskus Hospital, Muenster; M. Niewerth, MA, German Rheumatism Research Center, a Leibniz Institute, Berlin; J. Klotsche, PhD, German Rheumatism Research Center, a Leibniz Institute, and Charité – University Medicine Berlin, Institute for Social Medicine, Epidemiology and Health Economics, Berlin; K. Minden, MD, German Rheumatism Research Center, a Leibniz Institute, and Charité - University Medicine Berlin, Department of Rheumatology and Clinical Immunology, Berlin; A. Heiligenhaus, MD, Department of Ophthalmology at St. Franziskus Hospital, Muenster, and University of Duisburg-Essen, Essen, Germany. Dr. K. Walscheid and Dr. K. Glandorf contributed equally to this study. KW has received a DFG grant (WA 4449/2-1) and honoraria from Novartis. KM is funded by the Rheumastiftung and has received research grants from BMBF (FKZ, 01ER1504A), Pfizer, AbbVie, and Roche, and honoraria from AbbVie, Biermann, GSK, Medac, Sanofi. AH has received research grants from BMBF (FKZ, 01ER1504C), DFG (He 1877/19-1), Pfizer, and Novartis, and honoraria from AbbVie, Biermann, Alimera Sciences, Allergan, MSD Sharp and Dohme, Pfizer, Santen, and Xoma. Address correspondence to Dr. K. Walscheid, Department of Ophthalmology at St. Franziskus Hospital, Hohenzollernring 74, 48145 Muenster, Germany. Email: karoline.walscheid@uveitis-zentrum.de. Accepted for publication March 6, 2020.
Kai Rothaus
K. Walscheid, MD, FEBO, Department of Ophthalmology at St. Franziskus Hospital, Muenster, and Department of Ophthalmology, University Hospital Essen, Essen; K. Glandorf, MD, K. Rothaus, MSc, Department of Ophthalmology at St. Franziskus Hospital, Muenster; M. Niewerth, MA, German Rheumatism Research Center, a Leibniz Institute, Berlin; J. Klotsche, PhD, German Rheumatism Research Center, a Leibniz Institute, and Charité – University Medicine Berlin, Institute for Social Medicine, Epidemiology and Health Economics, Berlin; K. Minden, MD, German Rheumatism Research Center, a Leibniz Institute, and Charité - University Medicine Berlin, Department of Rheumatology and Clinical Immunology, Berlin; A. Heiligenhaus, MD, Department of Ophthalmology at St. Franziskus Hospital, Muenster, and University of Duisburg-Essen, Essen, Germany. Dr. K. Walscheid and Dr. K. Glandorf contributed equally to this study. KW has received a DFG grant (WA 4449/2-1) and honoraria from Novartis. KM is funded by the Rheumastiftung and has received research grants from BMBF (FKZ, 01ER1504A), Pfizer, AbbVie, and Roche, and honoraria from AbbVie, Biermann, GSK, Medac, Sanofi. AH has received research grants from BMBF (FKZ, 01ER1504C), DFG (He 1877/19-1), Pfizer, and Novartis, and honoraria from AbbVie, Biermann, Alimera Sciences, Allergan, MSD Sharp and Dohme, Pfizer, Santen, and Xoma. Address correspondence to Dr. K. Walscheid, Department of Ophthalmology at St. Franziskus Hospital, Hohenzollernring 74, 48145 Muenster, Germany. Email: karoline.walscheid@uveitis-zentrum.de. Accepted for publication March 6, 2020.
Martina Niewerth
K. Walscheid, MD, FEBO, Department of Ophthalmology at St. Franziskus Hospital, Muenster, and Department of Ophthalmology, University Hospital Essen, Essen; K. Glandorf, MD, K. Rothaus, MSc, Department of Ophthalmology at St. Franziskus Hospital, Muenster; M. Niewerth, MA, German Rheumatism Research Center, a Leibniz Institute, Berlin; J. Klotsche, PhD, German Rheumatism Research Center, a Leibniz Institute, and Charité – University Medicine Berlin, Institute for Social Medicine, Epidemiology and Health Economics, Berlin; K. Minden, MD, German Rheumatism Research Center, a Leibniz Institute, and Charité - University Medicine Berlin, Department of Rheumatology and Clinical Immunology, Berlin; A. Heiligenhaus, MD, Department of Ophthalmology at St. Franziskus Hospital, Muenster, and University of Duisburg-Essen, Essen, Germany. Dr. K. Walscheid and Dr. K. Glandorf contributed equally to this study. KW has received a DFG grant (WA 4449/2-1) and honoraria from Novartis. KM is funded by the Rheumastiftung and has received research grants from BMBF (FKZ, 01ER1504A), Pfizer, AbbVie, and Roche, and honoraria from AbbVie, Biermann, GSK, Medac, Sanofi. AH has received research grants from BMBF (FKZ, 01ER1504C), DFG (He 1877/19-1), Pfizer, and Novartis, and honoraria from AbbVie, Biermann, Alimera Sciences, Allergan, MSD Sharp and Dohme, Pfizer, Santen, and Xoma. Address correspondence to Dr. K. Walscheid, Department of Ophthalmology at St. Franziskus Hospital, Hohenzollernring 74, 48145 Muenster, Germany. Email: karoline.walscheid@uveitis-zentrum.de. Accepted for publication March 6, 2020.
Jens Klotsche
K. Walscheid, MD, FEBO, Department of Ophthalmology at St. Franziskus Hospital, Muenster, and Department of Ophthalmology, University Hospital Essen, Essen; K. Glandorf, MD, K. Rothaus, MSc, Department of Ophthalmology at St. Franziskus Hospital, Muenster; M. Niewerth, MA, German Rheumatism Research Center, a Leibniz Institute, Berlin; J. Klotsche, PhD, German Rheumatism Research Center, a Leibniz Institute, and Charité – University Medicine Berlin, Institute for Social Medicine, Epidemiology and Health Economics, Berlin; K. Minden, MD, German Rheumatism Research Center, a Leibniz Institute, and Charité - University Medicine Berlin, Department of Rheumatology and Clinical Immunology, Berlin; A. Heiligenhaus, MD, Department of Ophthalmology at St. Franziskus Hospital, Muenster, and University of Duisburg-Essen, Essen, Germany. Dr. K. Walscheid and Dr. K. Glandorf contributed equally to this study. KW has received a DFG grant (WA 4449/2-1) and honoraria from Novartis. KM is funded by the Rheumastiftung and has received research grants from BMBF (FKZ, 01ER1504A), Pfizer, AbbVie, and Roche, and honoraria from AbbVie, Biermann, GSK, Medac, Sanofi. AH has received research grants from BMBF (FKZ, 01ER1504C), DFG (He 1877/19-1), Pfizer, and Novartis, and honoraria from AbbVie, Biermann, Alimera Sciences, Allergan, MSD Sharp and Dohme, Pfizer, Santen, and Xoma. Address correspondence to Dr. K. Walscheid, Department of Ophthalmology at St. Franziskus Hospital, Hohenzollernring 74, 48145 Muenster, Germany. Email: karoline.walscheid@uveitis-zentrum.de. Accepted for publication March 6, 2020.
Kirsten Minden
K. Walscheid, MD, FEBO, Department of Ophthalmology at St. Franziskus Hospital, Muenster, and Department of Ophthalmology, University Hospital Essen, Essen; K. Glandorf, MD, K. Rothaus, MSc, Department of Ophthalmology at St. Franziskus Hospital, Muenster; M. Niewerth, MA, German Rheumatism Research Center, a Leibniz Institute, Berlin; J. Klotsche, PhD, German Rheumatism Research Center, a Leibniz Institute, and Charité – University Medicine Berlin, Institute for Social Medicine, Epidemiology and Health Economics, Berlin; K. Minden, MD, German Rheumatism Research Center, a Leibniz Institute, and Charité - University Medicine Berlin, Department of Rheumatology and Clinical Immunology, Berlin; A. Heiligenhaus, MD, Department of Ophthalmology at St. Franziskus Hospital, Muenster, and University of Duisburg-Essen, Essen, Germany. Dr. K. Walscheid and Dr. K. Glandorf contributed equally to this study. KW has received a DFG grant (WA 4449/2-1) and honoraria from Novartis. KM is funded by the Rheumastiftung and has received research grants from BMBF (FKZ, 01ER1504A), Pfizer, AbbVie, and Roche, and honoraria from AbbVie, Biermann, GSK, Medac, Sanofi. AH has received research grants from BMBF (FKZ, 01ER1504C), DFG (He 1877/19-1), Pfizer, and Novartis, and honoraria from AbbVie, Biermann, Alimera Sciences, Allergan, MSD Sharp and Dohme, Pfizer, Santen, and Xoma. Address correspondence to Dr. K. Walscheid, Department of Ophthalmology at St. Franziskus Hospital, Hohenzollernring 74, 48145 Muenster, Germany. Email: karoline.walscheid@uveitis-zentrum.de. Accepted for publication March 6, 2020.
Arnd Heiligenhaus
K. Walscheid, MD, FEBO, Department of Ophthalmology at St. Franziskus Hospital, Muenster, and Department of Ophthalmology, University Hospital Essen, Essen; K. Glandorf, MD, K. Rothaus, MSc, Department of Ophthalmology at St. Franziskus Hospital, Muenster; M. Niewerth, MA, German Rheumatism Research Center, a Leibniz Institute, Berlin; J. Klotsche, PhD, German Rheumatism Research Center, a Leibniz Institute, and Charité – University Medicine Berlin, Institute for Social Medicine, Epidemiology and Health Economics, Berlin; K. Minden, MD, German Rheumatism Research Center, a Leibniz Institute, and Charité - University Medicine Berlin, Department of Rheumatology and Clinical Immunology, Berlin; A. Heiligenhaus, MD, Department of Ophthalmology at St. Franziskus Hospital, Muenster, and University of Duisburg-Essen, Essen, Germany. Dr. K. Walscheid and Dr. K. Glandorf contributed equally to this study. KW has received a DFG grant (WA 4449/2-1) and honoraria from Novartis. KM is funded by the Rheumastiftung and has received research grants from BMBF (FKZ, 01ER1504A), Pfizer, AbbVie, and Roche, and honoraria from AbbVie, Biermann, GSK, Medac, Sanofi. AH has received research grants from BMBF (FKZ, 01ER1504C), DFG (He 1877/19-1), Pfizer, and Novartis, and honoraria from AbbVie, Biermann, Alimera Sciences, Allergan, MSD Sharp and Dohme, Pfizer, Santen, and Xoma. Address correspondence to Dr. K. Walscheid, Department of Ophthalmology at St. Franziskus Hospital, Hohenzollernring 74, 48145 Muenster, Germany. Email: karoline.walscheid@uveitis-zentrum.de. Accepted for publication March 6, 2020.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Enthesitis-related Arthritis: Prevalence and Complications of Associated Uveitis in Children and Adolescents From a Population-based Nationwide Study in Germany
Karoline Walscheid, Karen Glandorf, Kai Rothaus, Martina Niewerth, Jens Klotsche, Kirsten Minden, Arnd Heiligenhaus
The Journal of Rheumatology Mar 2020, jrheum.191085; DOI: 10.3899/jrheum.191085
Enthesitis-related Arthritis: Prevalence and Complications of Associated Uveitis in Children and Adolescents From a Population-based Nationwide Study in Germany
Karoline Walscheid, Karen Glandorf, Kai Rothaus, Martina Niewerth, Jens Klotsche, Kirsten Minden, Arnd Heiligenhaus
The Journal of Rheumatology Mar 2020, jrheum.191085; DOI: 10.3899/jrheum.191085